US Stock MarketDetailed Quotes

Ocular Therapeutix (OCUL)

Watchlist
  • 9.160
  • -0.340-3.58%
Close May 15 16:00 ET
  • 9.250
  • +0.090+0.98%
Post 18:49 ET
2.01BMarket Cap-6.36P/E (TTM)

Ocular Therapeutix (OCUL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-47.73%-65.99M
-52.13%-204.88M
-37.59%-54.25M
-38.75%-50.73M
-122.72%-55.24M
-31.82%-44.67M
-91.75%-134.68M
-75.60%-39.43M
-372.83%-36.56M
-23.55%-24.8M
Net income from continuing operations
-38.34%-88.61M
-37.43%-265.94M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
1.23%-64.05M
-139.68%-193.51M
-65.60%-48.39M
-6,972.29%-36.49M
-111.67%-43.78M
Operating gains losses
248.77%3.41M
-91.41%2.44M
4.49%-595K
120.45%1.45M
-79.78%612K
-97.05%978K
415.85%28.43M
-109.61%-623K
66.16%-7.08M
367.64%3.03M
Depreciation and amortization
30.78%1.28M
14.18%4.32M
31.13%1.25M
11.47%1.07M
7.32%1.03M
6.63%981K
26.92%3.79M
-0.73%951K
7.75%959K
46.63%956K
Other non cash items
-3.83%1.38M
-9.03%3.4M
-14.06%495K
22.06%758K
24.43%708K
-27.03%1.44M
-38.85%3.73M
-62.91%576K
-70.03%621K
-54.59%569K
Change In working capital
-82.61%962K
175.37%7.71M
-344.87%-2.1M
407.84%3.73M
-82.36%552K
142.52%5.53M
-38.04%-10.23M
113.09%858K
-119.46%-1.21M
168.34%3.13M
-Change in receivables
-12.06%6.3M
127.99%1.74M
105.48%118K
-11,766.67%-356K
-40.83%-5.19M
2,052.86%7.17M
-27.92%-6.21M
16.87%-2.15M
-100.08%-3K
40.40%-3.69M
-Change in inventory
24.45%-173K
28.71%-524K
88.03%-76K
-416.20%-449K
751.85%230K
14.87%-229K
-122.05%-735K
-1,222.92%-635K
367.92%142K
-56.45%27K
-Change in prepaid assets
-109.07%-357K
145.95%2.6M
-848.69%-2.9M
107.42%522K
-32.32%1.05M
2,973.44%3.93M
-50.37%-5.66M
89.56%-306K
-2,515.24%-7.04M
913.07%1.55M
-Change in payables and accrued expense
8.10%-4.72M
31.36%4.36M
-80.94%823K
-30.44%4.1M
-15.96%4.57M
58.36%-5.14M
144.84%3.32M
831.86%4.32M
107.45%5.9M
671.63%5.44M
-Change in other current assets
-1,687.18%-1.86M
158.81%1.31M
354.95%696K
76.53%549K
-201.85%-55K
-71.67%117K
-67.83%505K
-168.94%-273K
-19.01%311K
-85.52%54K
-Change in other current liabilities
790.63%1.77M
-38.79%-1.65M
-2,348.39%-759K
-43.62%-642K
105.70%11K
50.29%-256K
34.58%-1.19M
95.34%-31K
-63.74%-447K
63.58%-193K
-Change in other working capital
----
51.15%-128K
--0
--0
-3.23%-64K
-8.47%-64K
-161.36%-262K
50.00%-62K
39.69%-79K
-107.36%-62K
Cash from discontinued investing activities
Operating cash flow
-47.73%-65.99M
-52.13%-204.88M
-37.59%-54.25M
-38.75%-50.73M
-122.72%-55.24M
-31.82%-44.67M
-91.75%-134.68M
-75.60%-39.43M
-372.83%-36.56M
-23.55%-24.8M
Investing cash flow
Cash flow from continuing investing activities
-141.18%-4.66M
-822.36%-11.88M
-1,305.45%-2.84M
-6,633.71%-5.99M
-50.27%-1.12M
-658.04%-1.93M
78.84%-1.29M
55.99%-202K
65.64%-89K
62.71%-742K
Net PPE purchase and sale
-141.18%-4.66M
-822.36%-11.88M
-1,305.45%-2.84M
-6,633.71%-5.99M
-50.27%-1.12M
-658.04%-1.93M
78.84%-1.29M
55.99%-202K
65.64%-89K
62.71%-742K
Cash from discontinued investing activities
Investing cash flow
-141.18%-4.66M
-822.36%-11.88M
-1,305.45%-2.84M
-6,633.71%-5.99M
-50.27%-1.12M
-658.04%-1.93M
78.84%-1.29M
55.99%-202K
65.64%-89K
62.71%-742K
Financing cash flow
Cash flow from continuing financing activities
-92.97%294K
69.14%561.72M
9,857.37%449.38M
147.87%10.36M
4,353.83%97.81M
-98.70%4.18M
95.56%332.11M
-95.83%4.51M
-91.96%4.18M
-77.23%2.2M
Net issuance payments of debt
----
--0
----
----
----
----
--0
--0
--0
--0
Net common stock issuance
----
70.52%541.18M
85,098.28%446.44M
--0
19,155.69%94.74M
--0
168.70%317.37M
-99.52%524K
--0
-94.68%492K
Proceeds from stock option exercised by employees
-92.97%294K
39.37%20.54M
-26.37%2.94M
147.87%10.36M
80.05%3.07M
-14.11%4.18M
2,575.32%14.74M
49,762.50%3.99M
6,638.71%4.18M
322.83%1.7M
Cash from discontinued financing activities
Financing cash flow
-92.97%294K
69.14%561.72M
9,857.37%449.38M
147.87%10.36M
4,353.83%97.81M
-98.70%4.18M
95.56%332.11M
-95.83%4.51M
-91.96%4.18M
-77.23%2.2M
Net cash flow
Beginning cash position
87.62%738.67M
99.28%393.72M
-19.23%346.39M
-14.86%392.75M
-27.52%351.3M
99.28%393.72M
89.86%197.57M
281.82%428.83M
574.72%461.3M
499.89%484.65M
Current changes in cash
-65.86%-70.36M
75.87%344.96M
1,217.06%392.29M
-42.78%-46.36M
277.54%41.45M
-114.78%-42.42M
109.77%196.15M
-141.19%-35.12M
-173.89%-32.47M
-87.99%-23.35M
End cash Position
90.24%668.31M
87.62%738.67M
87.62%738.67M
-19.23%346.39M
-14.86%392.75M
-27.52%351.3M
99.28%393.72M
99.28%393.72M
281.82%428.83M
574.72%461.3M
Free cash flow
-51.61%-70.66M
-59.52%-216.89M
-44.05%-57.09M
-54.76%-56.72M
-121.12%-56.48M
-36.50%-46.6M
-78.15%-135.97M
-72.96%-39.63M
-358.62%-36.65M
-15.77%-25.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -47.73%-65.99M-52.13%-204.88M-37.59%-54.25M-38.75%-50.73M-122.72%-55.24M-31.82%-44.67M-91.75%-134.68M-75.60%-39.43M-372.83%-36.56M-23.55%-24.8M
Net income from continuing operations -38.34%-88.61M-37.43%-265.94M-33.62%-64.65M-90.22%-69.42M-54.91%-67.81M1.23%-64.05M-139.68%-193.51M-65.60%-48.39M-6,972.29%-36.49M-111.67%-43.78M
Operating gains losses 248.77%3.41M-91.41%2.44M4.49%-595K120.45%1.45M-79.78%612K-97.05%978K415.85%28.43M-109.61%-623K66.16%-7.08M367.64%3.03M
Depreciation and amortization 30.78%1.28M14.18%4.32M31.13%1.25M11.47%1.07M7.32%1.03M6.63%981K26.92%3.79M-0.73%951K7.75%959K46.63%956K
Other non cash items -3.83%1.38M-9.03%3.4M-14.06%495K22.06%758K24.43%708K-27.03%1.44M-38.85%3.73M-62.91%576K-70.03%621K-54.59%569K
Change In working capital -82.61%962K175.37%7.71M-344.87%-2.1M407.84%3.73M-82.36%552K142.52%5.53M-38.04%-10.23M113.09%858K-119.46%-1.21M168.34%3.13M
-Change in receivables -12.06%6.3M127.99%1.74M105.48%118K-11,766.67%-356K-40.83%-5.19M2,052.86%7.17M-27.92%-6.21M16.87%-2.15M-100.08%-3K40.40%-3.69M
-Change in inventory 24.45%-173K28.71%-524K88.03%-76K-416.20%-449K751.85%230K14.87%-229K-122.05%-735K-1,222.92%-635K367.92%142K-56.45%27K
-Change in prepaid assets -109.07%-357K145.95%2.6M-848.69%-2.9M107.42%522K-32.32%1.05M2,973.44%3.93M-50.37%-5.66M89.56%-306K-2,515.24%-7.04M913.07%1.55M
-Change in payables and accrued expense 8.10%-4.72M31.36%4.36M-80.94%823K-30.44%4.1M-15.96%4.57M58.36%-5.14M144.84%3.32M831.86%4.32M107.45%5.9M671.63%5.44M
-Change in other current assets -1,687.18%-1.86M158.81%1.31M354.95%696K76.53%549K-201.85%-55K-71.67%117K-67.83%505K-168.94%-273K-19.01%311K-85.52%54K
-Change in other current liabilities 790.63%1.77M-38.79%-1.65M-2,348.39%-759K-43.62%-642K105.70%11K50.29%-256K34.58%-1.19M95.34%-31K-63.74%-447K63.58%-193K
-Change in other working capital ----51.15%-128K--0--0-3.23%-64K-8.47%-64K-161.36%-262K50.00%-62K39.69%-79K-107.36%-62K
Cash from discontinued investing activities
Operating cash flow -47.73%-65.99M-52.13%-204.88M-37.59%-54.25M-38.75%-50.73M-122.72%-55.24M-31.82%-44.67M-91.75%-134.68M-75.60%-39.43M-372.83%-36.56M-23.55%-24.8M
Investing cash flow
Cash flow from continuing investing activities -141.18%-4.66M-822.36%-11.88M-1,305.45%-2.84M-6,633.71%-5.99M-50.27%-1.12M-658.04%-1.93M78.84%-1.29M55.99%-202K65.64%-89K62.71%-742K
Net PPE purchase and sale -141.18%-4.66M-822.36%-11.88M-1,305.45%-2.84M-6,633.71%-5.99M-50.27%-1.12M-658.04%-1.93M78.84%-1.29M55.99%-202K65.64%-89K62.71%-742K
Cash from discontinued investing activities
Investing cash flow -141.18%-4.66M-822.36%-11.88M-1,305.45%-2.84M-6,633.71%-5.99M-50.27%-1.12M-658.04%-1.93M78.84%-1.29M55.99%-202K65.64%-89K62.71%-742K
Financing cash flow
Cash flow from continuing financing activities -92.97%294K69.14%561.72M9,857.37%449.38M147.87%10.36M4,353.83%97.81M-98.70%4.18M95.56%332.11M-95.83%4.51M-91.96%4.18M-77.23%2.2M
Net issuance payments of debt ------0------------------0--0--0--0
Net common stock issuance ----70.52%541.18M85,098.28%446.44M--019,155.69%94.74M--0168.70%317.37M-99.52%524K--0-94.68%492K
Proceeds from stock option exercised by employees -92.97%294K39.37%20.54M-26.37%2.94M147.87%10.36M80.05%3.07M-14.11%4.18M2,575.32%14.74M49,762.50%3.99M6,638.71%4.18M322.83%1.7M
Cash from discontinued financing activities
Financing cash flow -92.97%294K69.14%561.72M9,857.37%449.38M147.87%10.36M4,353.83%97.81M-98.70%4.18M95.56%332.11M-95.83%4.51M-91.96%4.18M-77.23%2.2M
Net cash flow
Beginning cash position 87.62%738.67M99.28%393.72M-19.23%346.39M-14.86%392.75M-27.52%351.3M99.28%393.72M89.86%197.57M281.82%428.83M574.72%461.3M499.89%484.65M
Current changes in cash -65.86%-70.36M75.87%344.96M1,217.06%392.29M-42.78%-46.36M277.54%41.45M-114.78%-42.42M109.77%196.15M-141.19%-35.12M-173.89%-32.47M-87.99%-23.35M
End cash Position 90.24%668.31M87.62%738.67M87.62%738.67M-19.23%346.39M-14.86%392.75M-27.52%351.3M99.28%393.72M99.28%393.72M281.82%428.83M574.72%461.3M
Free cash flow -51.61%-70.66M-59.52%-216.89M-44.05%-57.09M-54.76%-56.72M-121.12%-56.48M-36.50%-46.6M-78.15%-135.97M-72.96%-39.63M-358.62%-36.65M-15.77%-25.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More